Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Growth (Status and Outlook) 2025-2031

January 2025 | 103 pages | ID: GE5308372414EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Forecast” looks at past sales and reviews total world B-Cell Maturation Antigen (BCMA) Targeted Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected B-Cell Maturation Antigen (BCMA) Targeted Therapies sales for 2025 through 2031. With B-Cell Maturation Antigen (BCMA) Targeted Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world B-Cell Maturation Antigen (BCMA) Targeted Therapies industry.

This Insight Report provides a comprehensive analysis of the global B-Cell Maturation Antigen (BCMA) Targeted Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on B-Cell Maturation Antigen (BCMA) Targeted Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global B-Cell Maturation Antigen (BCMA) Targeted Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for B-Cell Maturation Antigen (BCMA) Targeted Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global B-Cell Maturation Antigen (BCMA) Targeted Therapies.

This report presents a comprehensive overview, market shares, and growth opportunities of B-Cell Maturation Antigen (BCMA) Targeted Therapies market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Bispecific Antibodies
• Antibody Drug Conjugates
• Chimeric Antigen Receptor T-Cells

Segmentation by Application:

• Liver Cancer
• Respiratory Cancer
• Brain Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Transposagen Biopharmaceuticals
• Sutro Biopharma
• Malin Corporation
• Eureka Therapeutics
• firstVentury Equity
• Five Prime Therapeutics
• Credit Suisse Securities
• Dana-Farber Cancer Institute
• Deerfield Partners
• Onyx Pharmaceuticals
• Juno Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size (2020-2031)
  2.1.2 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for B-Cell Maturation Antigen (BCMA) Targeted Therapies by Country/Region (2020, 2024 & 2031)
2.2 B-Cell Maturation Antigen (BCMA) Targeted Therapies Segment by Type
  2.2.1 Bispecific Antibodies
  2.2.2 Antibody Drug Conjugates
  2.2.3 Chimeric Antigen Receptor T-Cells
2.3 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type
  2.3.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2020-2025)
2.4 B-Cell Maturation Antigen (BCMA) Targeted Therapies Segment by Application
  2.4.1 Liver Cancer
  2.4.2 Respiratory Cancer
  2.4.3 Brain Cancer
  2.4.4 Others
2.5 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application
  2.5.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2020-2025)

3 B-CELL MATURATION ANTIGEN (BCMA) TARGETED THERAPIES MARKET SIZE BY PLAYER

3.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Player
  3.1.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue by Player (2020-2025)
  3.1.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue Market Share by Player (2020-2025)
3.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 B-CELL MATURATION ANTIGEN (BCMA) TARGETED THERAPIES BY REGION

4.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Region (2020-2025)
4.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2020-2025)
4.4 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2020-2025)
4.5 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2020-2025)
4.6 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Country (2020-2025)
5.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2020-2025)
5.3 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Region (2020-2025)
6.2 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2020-2025)
6.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Country (2020-2025)
7.2 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2020-2025)
7.3 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies by Region (2020-2025)
8.2 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2020-2025)
8.3 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL B-CELL MATURATION ANTIGEN (BCMA) TARGETED THERAPIES MARKET FORECAST

10.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Region (2026-2031)
  10.1.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Region (2026-2031)
  10.1.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.1.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.1.4 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.1.5 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
10.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Country (2026-2031)
  10.2.1 United States Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.2.2 Canada Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.2.3 Mexico Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.2.4 Brazil Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
10.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Region (2026-2031)
  10.3.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast
  10.3.2 Japan Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.3.3 Korea Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.3.4 Southeast Asia Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.3.5 India Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.3.6 Australia Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
10.4 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Country (2026-2031)
  10.4.1 Germany Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.4.2 France Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.4.3 UK Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.4.4 Italy Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.4.5 Russia Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
10.5 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Region (2026-2031)
  10.5.1 Egypt Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.5.2 South Africa Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.5.3 Israel Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
  10.5.4 Turkey Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast
10.6 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Type (2026-2031)
10.7 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Transposagen Biopharmaceuticals
  11.1.1 Transposagen Biopharmaceuticals Company Information
  11.1.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Transposagen Biopharmaceuticals Main Business Overview
  11.1.5 Transposagen Biopharmaceuticals Latest Developments
11.2 Sutro Biopharma
  11.2.1 Sutro Biopharma Company Information
  11.2.2 Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.2.3 Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sutro Biopharma Main Business Overview
  11.2.5 Sutro Biopharma Latest Developments
11.3 Malin Corporation
  11.3.1 Malin Corporation Company Information
  11.3.2 Malin Corporation B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.3.3 Malin Corporation B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Malin Corporation Main Business Overview
  11.3.5 Malin Corporation Latest Developments
11.4 Eureka Therapeutics
  11.4.1 Eureka Therapeutics Company Information
  11.4.2 Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.4.3 Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Eureka Therapeutics Main Business Overview
  11.4.5 Eureka Therapeutics Latest Developments
11.5 firstVentury Equity
  11.5.1 firstVentury Equity Company Information
  11.5.2 firstVentury Equity B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.5.3 firstVentury Equity B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 firstVentury Equity Main Business Overview
  11.5.5 firstVentury Equity Latest Developments
11.6 Five Prime Therapeutics
  11.6.1 Five Prime Therapeutics Company Information
  11.6.2 Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.6.3 Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Five Prime Therapeutics Main Business Overview
  11.6.5 Five Prime Therapeutics Latest Developments
11.7 Credit Suisse Securities
  11.7.1 Credit Suisse Securities Company Information
  11.7.2 Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.7.3 Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Credit Suisse Securities Main Business Overview
  11.7.5 Credit Suisse Securities Latest Developments
11.8 Dana-Farber Cancer Institute
  11.8.1 Dana-Farber Cancer Institute Company Information
  11.8.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Dana-Farber Cancer Institute Main Business Overview
  11.8.5 Dana-Farber Cancer Institute Latest Developments
11.9 Deerfield Partners
  11.9.1 Deerfield Partners Company Information
  11.9.2 Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.9.3 Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Deerfield Partners Main Business Overview
  11.9.5 Deerfield Partners Latest Developments
11.10 Onyx Pharmaceuticals
  11.10.1 Onyx Pharmaceuticals Company Information
  11.10.2 Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Onyx Pharmaceuticals Main Business Overview
  11.10.5 Onyx Pharmaceuticals Latest Developments
11.11 Juno Therapeutics
  11.11.1 Juno Therapeutics Company Information
  11.11.2 Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered
  11.11.3 Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Juno Therapeutics Main Business Overview
  11.11.5 Juno Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. B-Cell Maturation Antigen (BCMA)TargetedTherapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Bispecific Antibodies
Table 4. Major Players of Antibody Drug Conjugates
Table 5. Major Players of Chimeric Antigen ReceptorT-Cells
Table 6. B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size byType (2020-2025) & ($ millions)
Table 8. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share byType (2020-2025)
Table 9. B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Application (2020-2025) & ($ millions)
Table 11. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Application (2020-2025)
Table 12. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue by Player (2020-2025) & ($ millions)
Table 13. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue Market Share by Player (2020-2025)
Table 14. B-Cell Maturation Antigen (BCMA)TargetedTherapies Key Players Head office and Products Offered
Table 15. B-Cell Maturation Antigen (BCMA)TargetedTherapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Region (2020-2025) & ($ millions)
Table 19. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Region (2020-2025)
Table 20. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Country (2020-2025)
Table 24. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size byType (2020-2025) & ($ millions)
Table 25. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share byType (2020-2025)
Table 26. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Application (2020-2025)
Table 28. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Region (2020-2025)
Table 30. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size byType (2020-2025) & ($ millions)
Table 31. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Country (2020-2025)
Table 34. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size byType (2020-2025) & ($ millions)
Table 35. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of B-Cell Maturation Antigen (BCMA)TargetedTherapies
Table 40. Key Market Challenges & Risks of B-Cell Maturation Antigen (BCMA)TargetedTherapies
Table 41. Key IndustryTrends of B-Cell Maturation Antigen (BCMA)TargetedTherapies
Table 42. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46.Transposagen Biopharmaceuticals Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 47.Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 48.Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49.Transposagen Biopharmaceuticals Main Business
Table 50.Transposagen Biopharmaceuticals Latest Developments
Table 51. Sutro Biopharma Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 52. Sutro Biopharma B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 53. Sutro Biopharma B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Sutro Biopharma Main Business
Table 55. Sutro Biopharma Latest Developments
Table 56. Malin Corporation Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 57. Malin Corporation B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 58. Malin Corporation B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Malin Corporation Main Business
Table 60. Malin Corporation Latest Developments
Table 61. EurekaTherapeutics Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 62. EurekaTherapeutics B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 63. EurekaTherapeutics B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. EurekaTherapeutics Main Business
Table 65. EurekaTherapeutics Latest Developments
Table 66. firstVentury Equity Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 67. firstVentury Equity B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 68. firstVentury Equity B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. firstVentury Equity Main Business
Table 70. firstVentury Equity Latest Developments
Table 71.Five PrimeTherapeutics Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 72.Five PrimeTherapeutics B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 73.Five PrimeTherapeutics B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74.Five PrimeTherapeutics Main Business
Table 75.Five PrimeTherapeutics Latest Developments
Table 76. Credit Suisse Securities Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 77. Credit Suisse Securities B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 78. Credit Suisse Securities B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Credit Suisse Securities Main Business
Table 80. Credit Suisse Securities Latest Developments
Table 81. Dana-Farber Cancer Institute Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 82. Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 83. Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Dana-Farber Cancer Institute Main Business
Table 85. Dana-Farber Cancer Institute Latest Developments
Table 86. Deerfield Partners Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 87. Deerfield Partners B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 88. Deerfield Partners B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Deerfield Partners Main Business
Table 90. Deerfield Partners Latest Developments
Table 91. Onyx Pharmaceuticals Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 92. Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 93. Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Onyx Pharmaceuticals Main Business
Table 95. Onyx Pharmaceuticals Latest Developments
Table 96. JunoTherapeutics Details, CompanyType, B-Cell Maturation Antigen (BCMA)TargetedTherapies Area Served and Its Competitors
Table 97. JunoTherapeutics B-Cell Maturation Antigen (BCMA)TargetedTherapies Product Offered
Table 98. JunoTherapeutics B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. JunoTherapeutics Main Business
Table 100. JunoTherapeutics Latest Developments



LIST OFFIGURES

Figure 1. B-Cell Maturation Antigen (BCMA)TargetedTherapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. B-Cell Maturation Antigen (BCMA)TargetedTherapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. B-Cell Maturation Antigen (BCMA)TargetedTherapies Sales Market Share by Country/Region (2024)
Figure 8. B-Cell Maturation Antigen (BCMA)TargetedTherapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share byType in 2024
Figure 10. B-Cell Maturation Antigen (BCMA)TargetedTherapies in Liver Cancer
Figure 11. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market: Liver Cancer (2020-2025) & ($ millions)
Figure 12. B-Cell Maturation Antigen (BCMA)TargetedTherapies in Respiratory Cancer
Figure 13. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market: Respiratory Cancer (2020-2025) & ($ millions)
Figure 14. B-Cell Maturation Antigen (BCMA)TargetedTherapies in Brain Cancer
Figure 15. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market: Brain Cancer (2020-2025) & ($ millions)
Figure 16. B-Cell Maturation Antigen (BCMA)TargetedTherapies in Others
Figure 17. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market: Others (2020-2025) & ($ millions)
Figure 18. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Application in 2024
Figure 19. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Revenue Market Share by Player in 2024
Figure 20. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Region (2020-2025)
Figure 21. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2020-2025 ($ millions)
Figure 22. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2020-2025 ($ millions)
Figure 23. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2020-2025 ($ millions)
Figure 25. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Value Market Share by Country in 2024
Figure 26. United States B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Region in 2024
Figure 31. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share byType (2020-2025)
Figure 32. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Application (2020-2025)
Figure 33. China B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 37. India B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Country in 2024
Figure 40. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share byType (2020-2025)
Figure 41. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Application (2020-2025)
Figure 42. Germany B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 43.France B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 44. UK B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market Share by Application (2020-2025)
Figure 50. Egypt B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 56. APAC B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 57. Europe B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 59. United States B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 60. Canada B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 61. Mexico B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 62. Brazil B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 63. China B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 64. Japan B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 65. Korea B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 67. India B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 68. Australia B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 69. Germany B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 70.France B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 71. UK B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 72. Italy B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 73. Russia B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 74. Egypt B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 75. South Africa B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 76. Israel B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 77.Turkey B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)
Figure 78. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries B-Cell Maturation Antigen (BCMA)TargetedTherapies Market Size 2026-2031 ($ millions)